Abbott Laboratories posted its largest-ever quarter for rapid diagnostics, according to a news release from data analytics and consulting firm GlobalData. The company’s rapid diagnostics segment sold ...
While COVID-19 case counts are currently on the decline in the U.S., the Department of Defense (DOD) thinks we can’t be too prepared. To secure more rapid diagnostic kits, the U.S. Army has inked a $1 ...
After weathering a nearly billion-dollar dip in rapid COVID testing revenues earlier this year, Abbott’s BinaxNow antigen test sales rebounded following the COVID-19 resurgence due to the delta ...
Infectious Disease Diagnostics Market Size To Reach USD 63.26 Billion By 2035, Driven By Rapid Testing Adoption And Molecular ...
INDIANAPOLIS, (WISH) – The holidays are about spreading joy, but it’s also a time when celebrating with friends and family can get us sick. On Tuesday, Dr. Mary Rodgers, a Ph.D. who is an Abbott ...
Narrow-moat Abbott ABT posted solid third-quarter results with underlying strength in its device business along with robust recovery in nutrition, which partially offset the ongoing unwinding of its ...
We’re not surprised by narrow-moat Abbott’s ABT recalibration of its outlook for COVID-19 testing now that the pandemic has been receding in developed markets. After fine-tuning our already more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results